INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Skye Bioscience, Inc.Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm

Core Points - A shareholder class action lawsuit has been filed against Skye Bioscience, Inc. alleging that the company made materially false and misleading statements regarding the effectiveness of nimacimab [1] - The lawsuit claims that the clinical, regulatory, and commercial prospects of nimacimab were overstated, leading to misleading public statements by the defendants [1] - The lawsuit covers shareholders who purchased shares between November 4, 2024, and October 3, 2025, and experienced significant losses [2] Legal Information - The deadline for shareholders to ask the court to be appointed lead plaintiff in the case is January 16, 2026 [3] - Holzer & Holzer, LLC is the law firm representing the shareholders, known for its vigorous representation in securities litigation [3]